1. Kahrilas PJ, Bredenoord AJ, Fox M, et al. International high resolution manometry working group. The Chicago classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27:160–74.
2. Denaxas K, Ladas SD, Karamanolis GP. Evaluation and management of esophageal manifestation in systemic sclerosis. Ann Gastroenterol. 2018;31(2):165–70.
3. Karamanolis GP, Denaxas K, Panopoulos S, et al. Severe esophageal disease and its associations in systemic sclerosis. Clin Exp Rheumatol. 2017;35((Suppl 106):106):82–5.
4. Hendel L, Hage E, Hendel J, Stentoft P. Omeprazole in the long-term treatment of severe gastrooesophageal reflux disease in patients with systemic sclerosis. Aliment Pharmacol Ther. 1992;6:565–77.
5. Pakozdi A, Wilson H, Black CM, Denton CP. Does long term therapy with lansoprazole slow progression of oesophageal involvement in systemic sclerosis? Clin Exp Rheumatol. 2009;27(3 Suppl 54):5–8.